Sarcoidosis. Current perspectives on diagnosis and treatment.
Sarcoidosis is a systemic noncaseous granulomatous disorder whose chief manifestation involves the lungs and intrathoracic lymph nodes in more than 90% of cases. New insights into pathogenesis and assessment of activity of the disease have been afforded by bronchoalveolar lavage, gallium citrate Ga 67 scanning, and measurement of serum angiotensin-converting enzyme. Current evidence favors early treatment with glucocorticoids to suppress the inflammatory element and thus prevent or minimize irreversible fibrosis.